ERBB2 and breast carcinoma: In the past 5 years, EQA of HER2-IHC in breast cancers in China has been performed by the Pathology Quality Control Centre (PQCC) of the National Health and Family Planning Commission with the aim of assessing consistency and accuracy regarding HER2-IHC in different pathology departments.